These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Drug discontinuation in depression]. Vanelle JM; Féline A Encephale; 1994 Apr; 20 Spec No 1():223-9. PubMed ID: 7913680 [TBL] [Abstract][Full Text] [Related]
44. [Long-term treatment of patients in neurological practices with antidepressive agents]. Schüssler G; Linden M; Müller-Oerlinghausen B Nervenarzt; 1984 Mar; 55(3):137-42. PubMed ID: 6425705 [No Abstract] [Full Text] [Related]
45. Reliability and validity of the assessment of antidepressant effects. Maier W; Philipp M; Buller R; Schlegel S Pharmacopsychiatry; 1988 Nov; 21(6):449-50. PubMed ID: 3244790 [No Abstract] [Full Text] [Related]
46. Drug treatment of depression in general practice. Wheatley D; Little JC Practitioner; 1982 Feb; 226(1364):316-20. PubMed ID: 7088828 [No Abstract] [Full Text] [Related]
47. [Long-term treatment with antidepressive drugs]. Lôo H; Brochier T Ann Med Psychol (Paris); 1995 May; 153(3):190-6; discussion 196-7. PubMed ID: 7598353 [TBL] [Abstract][Full Text] [Related]
48. Safety and efficacy of bupropion in elderly patients: preliminary observations. Kane JM; Cole K; Sarantakos S; Howard A; Borenstein M J Clin Psychiatry; 1983 May; 44(5 Pt 2):134-6. PubMed ID: 6406442 [TBL] [Abstract][Full Text] [Related]
49. Lithium-antidepressant combinations in the treatment of depressed, physically ill geriatric patients. Kushnir SL Am J Psychiatry; 1986 Mar; 143(3):378-9. PubMed ID: 3082221 [TBL] [Abstract][Full Text] [Related]
50. Adding lithium to antidepressant therapy: factors related to therapeutic potentiation. Rybakowski J; Matkowski K Eur Neuropsychopharmacol; 1992 Jun; 2(2):161-5. PubMed ID: 1633434 [TBL] [Abstract][Full Text] [Related]
52. Potentiation of antidepressant medications by phase advance of the sleep-wake cycle. Sack DA; Nurnberger J; Rosenthal NE; Ashburn E; Wehr TA Am J Psychiatry; 1985 May; 142(5):606-8. PubMed ID: 3985199 [TBL] [Abstract][Full Text] [Related]
53. After lithium augmentation: a retrospective follow-up of patients with antidepressant-refractory depression. Nierenberg AA; Price LH; Charney DS; Heninger GR J Affect Disord; 1990 Mar; 18(3):167-75. PubMed ID: 2139061 [TBL] [Abstract][Full Text] [Related]
54. Assessing the adequacy of past antidepressant trials: a clinician's guide to the antidepressant treatment response questionnaire. Desseilles M; Witte J; Chang TE; Iovieno N; Dording CM; Ashih H; Nyer M; Freeman MP; Fava M; Mischoulon D J Clin Psychiatry; 2011 Aug; 72(8):1152-4. PubMed ID: 21899818 [No Abstract] [Full Text] [Related]
55. Beyond the evidence: is there a place for antidepressant combinations in the pharmacotherapy of depression? Walters MJ; Unwin AM; Gills SB Med J Aust; 2007 Aug; 187(3):199; author reply 199-200. PubMed ID: 17726826 [No Abstract] [Full Text] [Related]
56. Augmentation of antidepressant therapy by buspirone: three geriatric case histories. Robillard M; Lieff S Can J Psychiatry; 1995 Dec; 40(10):639-40. PubMed ID: 8681264 [No Abstract] [Full Text] [Related]
58. How to improve the risk-benefit ratio of antidepressants. Corruble E; Puech AJ Int Clin Psychopharmacol; 1993; 8(4):237-41. PubMed ID: 8277141 [TBL] [Abstract][Full Text] [Related]
59. Thyroid hormone use to enhance the effects of drugs. Joffe RT; Singer W Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():389A-390A. PubMed ID: 1498887 [No Abstract] [Full Text] [Related]